|Day Low/High||2.39 / 2.40|
|52 Wk Low/High||0.82 / 3.10|
Jonathan Moreland, author of InsiderInsights, gives you the lowdown on top stock purchases and sales.
The stock takes a beating after company ends late-stage trial of GVAX.
Ched111 has a natural gas play, an industrial, some tech and a health care play among his holdings.
Schering-Plough shares find relief after the drugmaker unveils a $1.5 billion cost-cutting plan.
The market needs two more weeks of benign price action before real stability can return.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.